Utilization of Data Below the Analytical Limit of Quantitation in Pharmacokinetic Analysis and Modeling: Promoting Interdisciplinary Debate
- 23 July 2018
- journal article
- research article
- Published by Taylor & Francis in Bioanalysis
- Vol. 10 (15) , 1229-1248
Abstract
Traditionally, bioanalytical laboratories do not report actual concentrations for samples with results below the LOQ (BLQ) in pharmacokinetic studies. BLQ values are outside the method calibration range established during validation and no data are available to support the reliability of these values. However, ignoring BLQ data can contribute to bias and imprecision in model-based pharmacokinetic analyses. From this perspective, routine use of BLQ data would be advantageous. We would like to initiate an interdisciplinary debate on this important topic by summarizing the current concepts and use of BLQ data by regulators, pharmacometricians and bioanalysts. Through introducing the limit of detection and evaluating its variability, BLQ data could be released and utilized appropriately for pharmacokinetic research.Keywords
Funding Information
- UK NIH Research (ACF-2016-18-016)
- UK Medical Research Council Fellowships (G1002305)
- UK Medical Research Council Fellowships (M008665)
- Ministry of Education and Research of Estonia (TLOKT14014I)
This publication has 245 references indexed in Scilit:
- Scale Reduction of a Systems Coagulation Model With an Application to Modeling Pharmacokinetic–Pharmacodynamic DataCPT: Pharmacometrics & Systems Pharmacology, 2014
- Population Pharmacokinetics of Dexmedetomidine in Critically Ill PatientsClinical Drug Investigation, 2013
- Long-acting κ opioid antagonists nor-BNI, GNTI and JDTic: pharmacokinetics in mice and lipophilicityBMC Pharmacology, 2012
- Two-stage model-based design of cancer phase I dose escalation trials: evaluation using the phase I program of barasertib (AZD1152)Investigational New Drugs, 2011
- Increased Clearance of Morphine in Sickle Cell Disease: Implications for Pain ManagementThe Journal of Pain, 2011
- (R)‐ and (S)‐methadone and buprenorphine concentration ratios in maternal and umbilical cord plasma following chronic maintenance dosing in pregnancyBritish Journal of Clinical Pharmacology, 2010
- Nonlinear pharmacokinetics of piperacillin in healthy volunteers – implications for optimal dosage regimensBritish Journal of Clinical Pharmacology, 2010
- Voriconazole Pharmacokinetics and Pharmacodynamics in ChildrenClinical Infectious Diseases, 2010
- Evaluation of different tests based on observations for external model evaluation of population analysesJournal of Pharmacokinetics and Pharmacodynamics, 2009
- Ad‐optimal designed population pharmacokinetic study of oral itraconazole in adult cystic fibrosis patientsBritish Journal of Clinical Pharmacology, 2006